Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KB 944

Known as: KB-944 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1987
Review
1987
  • N. Taira
  • The American journal of cardiology
  • 1987
  • Corpus ID: 31832902
Calcium antagonists constitute a group of organic compounds with diverse chemical structures. Although their main pharmacodynamic… Expand
1986
1986
A series of 4-(benzothiazol-2-yl)benzylphosphonic acid dialkyl ester derivatives were synthesized and evaluated for coronary… Expand
1985
1985
The anti-anginal effects of KB-944 (Fostedil), a new calcium ion antagonist with a half life of approximately 23-28 hr, were… Expand
1985
1985
Tritiated 1,4-dihydropyridines (nimodipine, nitrendipine, nifedipine, PN 200-110) and [3H]D-cis-diltiazem as well as [3H… Expand
1984
1984
The cardiac electrophysiologic actions of a novel calcium antagonist, KB-944 [Fostedil, Abbott-53986, diethyl 4-(benzothiazol-2… Expand
1983
1983
Summary We compared the cardiac and coronary vasodilator actions of a new calcium-antagonistic vasodilator, KB-944, in isolated… Expand
1982
1982
A comparative study was made between the cardiac action of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) and those of… Expand
1982
1982
Vasodilator action of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) was mainly examined in comparison with papaverine… Expand
1982
1982
The vasodilator mechanism of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) was investigated in anesthetized dogs and… Expand
1982
1982
Hypotensive effect of KB-944 was examined in comparison with diltiazem and nifedipine in normotensive rats, spontaneously… Expand